Health
Sickle Cell Disease Treatment Market Research Report 2025 Featuring Novartis, Pfizer, Bluebird Bio, GlycoMimetics, Emmaus Medical, BMS, CRISPR Therapeutics, Graphite Bio
The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and advocacy have spurred global initiatives for better diagnosis, research funding, and equitable access, addressing unmet needs and fostering partnerships. Sickle Cell Disease Treatment Market Sickle Cell Disease Treatment Market Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatmen
About this update from Novartis Ag
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"The Sickle Cell Disease Treatment Market offers significant opportunities with advancements in gene editing, stem cell therapies, and precision medicine driving innovation. Increased awareness and advocacy have spurred global initiatives for better diagnosis, research funding, and equitable access, addressing unmet needs and fostering partnerships.","length":350,"tagName":"p"},{"type":"text","content":"Sickle Cell Disease Treatment Market","length":36,"tagName":"p"},{"type":"image","alt":"Sickle Cell Disease Treatment Market","displaySize":"","headline":null,"caption":"Sickle Cell Disease Treatment Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/3c0198f65e137ab2870336e6d2f046d7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/1UIoj8QNhumDOEaYMs8mLQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/3c0198f65e137ab2870336e6d2f046d7","width":600,"height":400}}},{"type":"text","content":"Dublin, Nov. 11, 2025 (GLOBE NEWSWIRE) -- The "Sickle Cell Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Sickle Cell Disease Treatment Market was valued at USD 1.22 Billion in 2024, and is expected to reach USD 3.12 Billion by 2030, rising at a CAGR of 16.91%.","length":397,"tagName":"p"},{"type":"text","content":"Sickle Cell Disease (SCD) is a genetic disorder characterized by the presence of abnormal hemoglobin, resulting in the deformation of red blood cells into a crescent or "sickle" shape. This altered cell structure leads to various complications, such as chronic pain, anemia, organ damage, and a shortened lifespan. ","...